FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094910 [Registered on: 16/09/2025] Trial Registered Prospectively
Last Modified On: 15/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Use of Local Anesthetic Drugs in Management of Labour Pain in Pregnant Women. 
Scientific Title of Study   Comparison of Continuous Infusion VS. Intermittent Bolus Administration of Epidural Levobupivacaine (0.125%) With Fentanyl For Labour Analgesia. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Gurulingappa I Herakal 
Designation  Phd Scholar 
Affiliation  Srinivas University Institute of Allied Health Sciences 
Address  Srinivas University Institute of Department of Anesthesiology, Ground Floor, A Block, Room Number 102, Allied Health Sciences Mukka Shasihithlu.

Dakshina Kannada
KARNATAKA
575025
India 
Phone  8880985164  
Fax    
Email  nikhilherakal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prashanthkumar C 
Designation  Professor 
Affiliation  Srinivas University 
Address  Srinivas University Institute of Department of Anesthesiology, Ground Floor, A Block, Room Number 102, Allied Health Sciences Mukka Shasihithlu.

Dakshina Kannada
KARNATAKA
575025
India 
Phone  9738400843  
Fax    
Email  drprashanthkumarc@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Gurulingappa I Herakal 
Designation  Phd Scholar 
Affiliation  Srinivas University Institute of Allied Health Sciences 
Address  Srinivas University Institute of Department of Anesthesiology, Ground Floor, A Block, Room Number 102, Allied Health Sciences Mukka Shasihithlu.


KARNATAKA
575025
India 
Phone  8880985164  
Fax    
Email  nikhilherakal@gmail.com  
 
Source of Monetary or Material Support  
Srinivas Institute of Medical Sciences and Research Centre 
 
Primary Sponsor  
Name  Gurulingappa I Herakal 
Address  Srinivas Institute of Medical Sciences and Research Centre Mukka Shasihithlu Karnataka 575025 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prashanthkumar C  Department of Anesthesiology and Critical Care Ground Floor Room number 1  Srinivas Institute of Medical Sciences and Research Centre Mukka Shasihithlu
Dakshina Kannada
KARNATAKA 
9738400843

drprashanthkumarc@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SrinivasUniversityEthicsCommittee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  pregnancy 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Group 1 Continuous InfusionPatients were positioned in either the sitting or lateral decubitus position for epidural placement. The insertion site (L3–L4 or L4–L5 interspace) was sterilized with an antiseptic solution, and lidocaine was administered for local infiltration. An epidural catheter was inserted at the L3–L4 or L4–L5 interspace, and correct placement was confirmed by aspiration and a test dose of 3 mL lidocaine with epinephrine. A continuous infusion of levobupivacaine 0.125% with fentanyl 2 µg/mL was started at a rate of 8–12 mL/h, adjusted according to clinical response.
2Comparator Arm (Non Ayurveda)-Group 2 Intermittent Bolus AdministritionPatients were positioned in either the sitting or lateral decubitus position for epidural placement. The insertion site (L3–L4 or L4–L5 interspace) was sterilized with an antiseptic solution, and lidocaine was administered for local infiltration. An epidural catheter was inserted at the L3–L4 or L4–L5 interspace, and correct placement was confirmed by aspiration and a test dose of 3 mL lidocaine with epinephrine. An initial bolus of 10 mL levobupivacaine 0.125% with fentanyl 100 µg was given after confirming catheter placement. Maintenance of epidural analgesia was achieved by administering bolus doses of 5–10 mL levobupivacaine 0.125% with fentanyl 50–100 µg depending on the participant’s pain level (VAS score) and cervical dilation.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1. Pregnant women aged 18 to 45 years.
2. Pregnant women at term, defined as 37 to 42 weeks of gestation.
3. Singleton pregnancy.
4. Pregnant women in active labor, defined as regular contractions with cervical dilation of at least 3 cm.
5. Labor Analgesia Requirement:
6. Pregnant women seeking epidural analgesia for labor pain relief.
7. Participants willing and able to provide informed consent.
 
 
ExclusionCriteria 
Details  1. Pregnant women outside the term pregnancy range (less than 37 or more than 42 weeks of gestation).
2. Multiple gestation (e.g., twins, triplets).
3. Pregnant women with contraindications to epidural analgesia, such as bleeding disorders or infection at the insertion site.
4. Known allergies to Levobupivacaine, fentanyl, or any of the components used in the epidural analgesia solution.
5. Pregnant women with pre-existing medical conditions that may complicate labor or epidural administration, such as severe heart disease or uncontrolled hypertension.
5. Pregnant women unable to communicate effectively or provide feedback regarding their pain level during labor (e.g., due to cognitive impairment).
6. Women with unstable labor, including non-reassuring fetal status or other obstetric emergencies.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The expected outcomes of this study comparing continuous infusion versus intermittent bolus administration of epidural Levobupivacaine with fentanyl for labor analgesia are multifaceted and can contribute significantly to the field of obstetrics and anaesthesiology.  Baseline Between 3 week and 6 week. 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the potential benefits of continuous infusion & intermittent bolus administration of epidural Levobupivacaine 0.125% with fentanyl for labour analgesia  Baseline of 9 week & 10 week. 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   30/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The research can identify areas that require further investigation, potentially paving the way for future studies on optimizing labor analgesia techniques. Ultimately, the expected outcomes of this PhD research study can provide valuable insights into the choice of epidural analgesia administration methods during labor, helping healthcare providers make informed decisions and potentially improving the overall experience and safety of laboring women.

 
Close